02 December 2020 : Clinical Research
A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China
Shuang Huang1C, Changxin Shen1B, Chengliang Xia1F, Xiaoxing Huang1C, Yourong Fu1A, Li Tian1E*DOI: 10.12659/MSM.928755
Med Sci Monit 2020; 26:e928755
Table 1 The clinical characteristics of the 24 patients with COVID-19 pneumonia who were treated with COVID-19 convalescent plasma during February and March 2020 at 2 centers in Wuhan, China.
| Patient no. | Sex | Age | Clinical classification | Comorbidiy | Days from admission to CCP transfusion | Days from CCP transfusion to discharge | Total transfusion volume, mL |
|---|---|---|---|---|---|---|---|
| 1 | F | 53 | Critical | Hypertension | 13 | 3 | 700 |
| 2 | F | 80 | Critical | None | 19 | 12 | 400 |
| 3 | F | 56 | Critical | Others | 19 | 8 | 800 |
| 4 | M | 31 | Critical | Others | 14 | 18 | 200 |
| 5 | M | 62 | Severe | Hypertension | 29 | 5 | 400 |
| 6 | F | 62 | Critical | Diabetes, CHD | 4 | 3 | 200 |
| 7 | M | 62 | Severe | Hyperlipidemia, fatty liver | 8 | 6 | 800 |
| 8 | M | 62 | Critical | Hypertension | 11 | 3 | 600 |
| 9 | M | 71 | Critical | Hypertension, CHD | 42 | 14 | 200 |
| 10 | F | 77 | Critical | Hypertension, CHD | 15 | 31 | 300 |
| 11 | M | 83 | Critical | Diabetes | 44 | 10 | 400 |
| 12 | M | 81 | Critical | Hypertension, CHD | 43 | 5 | 200 |
| 13 | M | 86 | Severe | Hypertension, CHD | 36 | 8 | 200 |
| 14 | M | 57 | Critical | Hypertension | 28 | 12 | 1200 |
| 15 | M | 64 | Severe | Diabetes, lymphoma | 24 | 15 | 200 |
| 16 | M | 47 | Critical | Diabetes, others | 17 | 2 | 400 |
| 17 | M | 68 | Severe | Hypertension, diabetes | 16 | 6 | 800 |
| 18 | F | 62 | Severe | Hypertension | 36 | 2 | 425 |
| 19 | F | 58 | Severe | None | 28 | 5 | 600 |
| 20 | F | 79 | Severe | Hypertension | 11 | 4 | 600 |
| 21 | F | 81 | Critical | Chronic heart failure, others | 12 | 6 | 200 |
| 22 | F | 81 | Severe | Ventricular contraction, lymphoma | 9 | 13 | 200 |
| 23 | F | 81 | Severe | Hypertension, MI, RA, uremia | 6 | 4 | 800 |
| 24 | M | 63 | Critical | Hypertension, diabetes, CRF | 19 | 2 | 400 |
| F – Female; M – Male; CHD – coronary heart disease; MI -– myocardial infarction; RA – rheumatoid arthritis; CRF –chronic renal failure; CCP – COVID-19 convalescent plasma. | |||||||